Clinical Outcomes and Safety Profile of Neoadjuvant PD-1 Inhibitors Combined With VEGFR-TKI Versus VEGFR-TKI in Nonmetastatic Renal Cell CarcinomaCheoklong Ng, Jiwei Huang, Pei Dong et al.|Clinical Genitourinary Cancer|2025Cited by 0